chr19-52929262-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001202473.2(ZNF816-ZNF321P):c.343T>A(p.Phe115Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000325 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001202473.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF816-ZNF321P | NM_001202473.2 | c.343T>A | p.Phe115Ile | missense_variant | 4/4 | ||
ZNF321P | NR_037805.1 | n.207T>A | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF321P | ENST00000313956.4 | n.214T>A | non_coding_transcript_exon_variant | 2/2 | 2 | ||||
ZNF321P | ENST00000550843.1 | n.136T>A | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152018Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000295 AC: 74AN: 251184Hom.: 0 AF XY: 0.000324 AC XY: 44AN XY: 135864
GnomAD4 exome AF: 0.000326 AC: 476AN: 1461872Hom.: 0 Cov.: 31 AF XY: 0.000322 AC XY: 234AN XY: 727236
GnomAD4 genome AF: 0.000322 AC: 49AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2024 | The c.343T>A (p.F115I) alteration is located in exon 4 (coding exon 3) of the ZNF816-ZNF321P gene. This alteration results from a T to A substitution at nucleotide position 343, causing the phenylalanine (F) at amino acid position 115 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at